Whole Genome Bisulfite Sequencing (WGBS) is the gold-standard method for comprehensive genome-wide DNA methylation analysis at single-base resolution. By combining bisulfite conversion with next-generation sequencing (NGS), WGBS enables precise detection of methylated cytosines across the entire genome, providing an unbiased view of epigenetic modifications.
WGBS is widely used to investigate gene regulation, development, disease mechanisms, cancer epigenetics, and biomarker discovery, making it one of the most powerful tools for methylome research.
DNA methylation is one of the most important epigenetic modifications, playing a central role in regulating gene expression, genomic stability, cellular differentiation, genomic imprinting, X-chromosome inactivation, and transposon silencing.
WGBS analyzes methylation across the entire genome, allowing researchers to identify methylated cytosines in CpG, CHG, and CHH contexts with single-nucleotide precision. Because it captures virtually all methylation events without prior target selection, WGBS provides the most comprehensive and unbiased methylation landscape available.
WGBS relies on bisulfite conversion, which selectively converts unmethylated cytosines into uracil while leaving methylated cytosines unchanged.
Following conversion:
• This workflow enables accurate quantification of DNA methylation throughout the genome.
Investigate how DNA methylation influences gene activation and silencing.
Identify methylation biomarkers and study epigenetic changes associated with tumor initiation, progression, and treatment response.
Explore DNA methylation dynamics during embryonic development, stem cell differentiation, and cellular reprogramming.
Examine methylation alterations linked to neurological, cardiovascular, metabolic, autoimmune, and other complex diseases.
Evaluate the impact of environmental factors, nutrition, and lifestyle on genome-wide methylation patterns.
Study epigenetic diversity, adaptation, breeding, and trait inheritance across plants and animals.
Investigate genomic imprinting, transposable element regulation, and mechanisms that maintain genome integrity.
| Technology | Resolution | Coverage | Best For |
|---|---|---|---|
| 850K Methylation Array | Single-base | ~850,000 predefined CpG sites | Large cohort studies and clinical methylation profiling |
| MeDIP-Seq | Regional | Genome-wide enriched methylated regions | Differential methylation screening without single-base resolution |
| WGBS | Single-base | Whole genome | Comprehensive, unbiased methylome analysis |
| RRBS | Single-base | CpG-rich regions | Cost-effective analysis of promoters and regulatory regions |
| Targeted Bisulfite Sequencing | Single-base | Selected genomic regions | Biomarker validation and targeted methylation studies |
| EM-Seq | Single-base | Genome-wide | Low-input samples with improved DNA preservation and library quality |
Our optimized WGBS workflow delivers highly accurate and reproducible whole-genome methylation profiling.
• Genomic DNA extraction and quality assessment
• Bisulfite conversion of genomic DNA
• Library preparation and quality control
• High-throughput sequencing on Illumina platforms
• Bioinformatics analysis, including:
DNA Methylation Microarray Services
N2Jenomics Lab Pvt. Ltd. offers advanced DNA methylation microarray services for high-throughput, genome-wide epigenetic profiling. Our microarray platforms enable accurate, reproducible, and cost-effective analysis of DNA methylation patterns, making them ideal for biomarker discovery, disease research, population studies, and clinical epigenetics.
We provide comprehensive solutions using the latest Illumina methylation arrays, supported by standardized laboratory workflows and expert bioinformatics analysis.
The Illumina Infinium MethylationEPIC v2.0 BeadChip (935K) enables genome-wide analysis of approximately 935,000 CpG sites across the human genome.
The Illumina MSA 270K is designed for efficient methylation screening in large cohort studies and population-scale research.
Our optimized Whole Genome Bisulfite Sequencing workflow ensures reliable and high-quality methylation profiling.
• DNA extraction and quality assessment
• Bisulfite conversion of genomic DNA
• Library preparation and Illumina adapter ligation
• High-throughput sequencing
• Comprehensive bioinformatics analysis
• Quality assessment and final reporting
Each step is performed under rigorous quality control to ensure accurate and reproducible results.
We support samples from a wide range of organisms, including:
| Sample Type | Recommended Requirement |
|---|---|
| Genomic DNA | ≥1 µg, ≥10 ng/µL, OD260/280 of 1.8–2.0 |
| Cultured Cells | ≥1 × 10⁶ cells |
| Tissue Samples | ≥50 mg |
High-quality DNA with minimal degradation is recommended for optimal sequencing performance.
Our comprehensive bioinformatics pipeline includes:
Upon project completion, you will receive:
WGBS can be applied to a wide range of eukaryotic organisms, including humans, animals, and plants. For optimal analysis, the species should have:
• A high-quality reference genome enables accurate read alignment, methylation calling, and downstream bioinformatics analysis.
Our WGBS bioinformatics pipeline provides comprehensive methylation analysis, including:
These analyses provide valuable insights into epigenetic regulation and biological function.
WGBS is considered the gold standard for DNA methylation analysis because it provides the most comprehensive and unbiased view of the methylome.
Key advantages include:
• Compared with MeDIP-Seq, WGBS provides base-level methylation information rather than relative enrichment. Compared with RRBS, WGBS offers complete genome coverage instead of focusing only on CpG-rich regions.
Although WGBS is the most comprehensive DNA methylation sequencing method, several considerations should be taken into account: